In March 2025, the company declared new options for any immediate-to-client presenting of its Wegovy weight loss drug. The company set up a fresh pharmacy, referred to as NovoCare, which would charge consumers $499 monthly for entry to the drug, a lot less than 50 percent the cost of the drug through other pharmaceutical distribution networks.[fift